| Enhance the neuromuscular effect of NMBAs | | Acetylcholinesterase inhibitors* | | Donepezil | | Galantamine | | Echothiophate iodine* | | Neostigmine | | Physostigmine | | Pyridostigmine | | Rivastigmine | | Tacrine | | Antibiotics | | Aminoglycosides | | Amikacin | | Gentamicin | | Kanamycin | | Neomycin | | Streptomycin | | Tobramycin | | Amphotericin B | | Colistin | | Lincosamides | | Clindamycin | | Lincomycin | | Polymyxin B | | Calcium channel blockers¶ | | Amlodipine | | BepridilΔ | | Clevidipine | | Diltiazem | | Felodipine | | Isradipine | | Nicardipine | | Nifedipine | | NilvadipineΔ | | Nimodipine | | Nisoldipine, nitrendipineΔ | | Verapamil | | Cyclophosphamide* | | Loop diuretics (low doses) | | Bumetanide | | Ethacrynic acid | | Furosemide | | Torsemide | | Magnesium Salts | | Phenelzine* | | Quinidine | | Quinine | | Trimebutine¶Δ | | | Diminish the neuromuscular effect of NMBAs | | Acetylcholinesterase inhibitors¶ | | Donepezil | | Galantamine | | Neostigmine | | Physostigmine | | Pyridostigmine | | Rivastigmine | | Tacrine | | Loop diuretics (high doses) | | Bumetanide | | Ethacrynic acid | | Furosemide | | Torsemide | |
